THE FEET OF CLAY OF THE DOUBLE-BLIND TRIAL

scientific article published on 01 November 1963

THE FEET OF CLAY OF THE DOUBLE-BLIND TRIAL is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(63)90693-7
P953full work available at URLhttps://api.elsevier.com/content/article/PII:S0140673663906937?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0140673663906937?httpAccept=text/plain
P698PubMed publication ID14059066

P2093author name stringB. W. CROMIE
P2860cites workClinical Pharmacology & TherapeuticsQ1101529
The symptomatic relief of anxiety with meprobamate, phenobarbital and placeboQ43996889
Clinical trial of methyprylone, a piperidine hypnoticQ50326742
An evaluation of the double-blind trial as a method of assessing promazine ("Sparine") in the treatment of chronic psychotic patients.Q52141835
Placebo response.Q52166619
The similarities and differences between meprobamate and barbiturates.Q52355305
Double-blind trials of promazine in labour.Q52765422
A trial of five tranquillizing drugs in psychoneurosis.Q55051366
Effects of placebo administration and occurrence of toxic reactionsQ73464264
Action of triethanolamine trinitrate in angina pectorisQ73603464
Postoperative pain: research and treatmentQ74092575
Factors influencing clinical evaluation of drugs; with special reference to the double-blind techniqueQ78278363
Gastrointestinal intolerance to oral iron preparationsQ78337457
Symposium on clinical drug evaluation and human pharmacology. XVII. Physicochemical and pharmaceutic properties of drugs that influence the results of clinical trialsQ79031283
An assessment of the responses to drugs acting on the central nervous systemQ79108291
A method of testing analgesics in manQ79496679
A comparative trial of trimeprazine and amylobarbitone in pruritusQ79518906
practitionerQ111608397
P433issue7315
P407language of work or nameEnglishQ1860
P921main subjectpharmacologyQ128406
non-opioid analgesicQ1747785
Analgesics and AntipyreticsQ56113559
Tranquilizing agentsQ74453648
P304page(s)994-997
P577publication date1963-11-01
P1433published inThe LancetQ939416
P1476titleTHE FEET OF CLAY OF THE DOUBLE-BLIND TRIAL
P478volume2

Reverse relations

cites work (P2860)
Q35187697Cimetidine suspension as adjuvant to energy restricted diet in treating obesity
Q28363521Comparison of Aspirin and Benorylate in the Treatment of Rheumatoid Arthritis
Q28363614Double-bind cross-over tiral of flurbiprofen and phenylbutazone in ankylosing spondylitis
Q93524003Double-blind cross-over study of ketoprofen and ibuprofen in management of rheumatoid arthritis
Q70100312Evaluating drug trials unseen
Q70100316Fatal "lomotil" poisoning
Q70111557Formulation and therapeutic efficacy of drugs used in clinical trials
Q52909196Management of Clinical Research “Architecture”
Q39932250Reflections on controlled trial
Q64983475Simple analgesics for arthritis.
Q36579584Some problems in the statistical analysis of clinical trial data
Q78298996TOLNAFTATE IN DERMATOLOGY: A NEW, POTENT TOPICAL FUNGICIDE
Q69933166Trial Management in Psychopharmacology. The Roles and Tasks of an Industry Physician
Q84447318Use of a placebo in clinical trials
Q41787411Validity of cross-over trials [editorial]
Q72973553[Double or single blind test in a short term pharmacologic experiment? Effect of psychopharmaca on the function of the autonomic nervous system in healthy persons in this experiment]

Search more.